Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other MS therapies have been presented at a Lisbon conference.
International study looks at long-term progression in people with MS following stem cell therapy
Rebooting immune system provides long term relief for aggressive relapsing MS in Canadian study
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) is being investigated as a treatment for MS
The results of a multi-centre, phase II, randomized trial
The Mesenchymal Stem Cell Therapy for Canadian MS Patients Study is part of a larger international research effort
Study shows improvement in neurological disability and other clinical outcomes
One day stem cells could be used to treat MS, but research into this is still in its early stages